Reprogramming Chronic Care: AI-Driven Digital Therapeutics for a Connected, Personalized and Equitable Health Future  

References

• Acosta, J. A. (2025). Perspective: Advancing public health education by embedding AI literacy. Frontiers in Digital Health, 7, 1584883. https://doi.org/10.3389/FDGTH.2025.1584883
• Ali, M. M., Nazneen, A., & Thaploo, V. (2024). Telehealth, the light at the end of the tunnel-A ray of hope for rural and remote healthcare. International Journal of Clinical Studies and Medical Case Reports, 33(5).
• Allison, S., Bastiampillai, T., Looi, J. C. L., Kisely, S. R., & Lakra, V. (2023). The new World Mental Health Report: Believing impossible things. Australasian Psychiatry, 31(2), 182. https://doi.org/10.1177/10398562231154806
• Ambrosi, E., Mezzalira, E., Canzan, F., Leardini, C., Vita, G., Marini, G., & Longhini, J. (2025). Effectiveness of digital health interventions for chronic conditions management in European primary care settings: Systematic review and meta-analysis. International Journal of Medical Informatics, 196, 105820. https://doi.org/10.1016/J.IJMEDINF.2025.105820
• Anawade, P. A., Sharma, D., & Gahane, S. (2024). A comprehensive review on exploring the impact of telemedicine on healthcare accessibility. Cureus, 16(3), e55996. https://doi.org/10.7759/CUREUS.55996
• Arcà, E., Heldt, D., & Smith, M. (2025). Comparison of health technology assessments for digital therapeutics in Germany, the United Kingdom and France. Digital Health, 11. https://doi.org/10.1177/20552076241308704
• Armeni, P., Polat, I., De Rossi, L. M., Diaferia, L., Meregalli, S., & Gatti, A. (2024). Exploring the potential of digital therapeutics: An assessment of progress and promise. Digital Health, 10. https://doi.org/10.1177/20552076241277441
• Arsalan, H. (2025). Enhancing predictive healthcare using AI-driven early warning systems. Proceedings of the AAAI Conference on Artificial Intelligence, 39(28), 29564–29566. https://doi.org/10.1609/AAAI.V39I28.35326
• Asif, M., & Gaur, P. (2025). The impact of digital health technologies on chronic disease management. Telehealth and Medicine Today, 10(1). https://doi.org/10.30953/THMT.V10.556
• Ayaz, M., Pasha, M. F., Alzahrani, M. Y., Budiarto, R., & Stiawan, D. (2021). The Fast Health Interoperability Resources (FIHR) standard: Systematic literature review of implementations, applications, challenges and opportunities. JMIR Medical Informatics, 9(7). https://doi.org/10.2196/21929
• Beatty, C., Malik, T., Meheli, S., & Sinha, C. (2022). Evaluating the therapeutic alliance with a free-text CBT conversational agent (Wysa): A mixed-methods study. Frontiers in Digital Health, 4, 847991.
• Biskupiak, Z., Ha, V. V., Rohaj, A., & Bulaj, G. (2024). Digital therapeutics for improving effectiveness of pharmaceutical drugs and biological products: Preclinical and clinical studies supporting development of drug + digital combination therapies for chronic diseases. Journal of Clinical Medicine, 13(2), 403. https://doi.org/10.3390/JCM13020403
• Bodner, E., Roth, L., Wiencke, K., Bischoff, C., & Schwarz, P. E. (2025). Effect of multimodal app-based interventions on glycemic control in patients with type 2 diabetes: Systematic review and meta-analysis. Journal of Medical Internet Research, 27, e54324.
• Bolpagni, M., Pardini, S., & Gabrielli, S. (2024). Human-centered design of AI-powered digital therapeutics for stress prevention: Perspectives from multi-stakeholders’ workshops about the SHIVA solution. Internet Interventions, 38, 100775. https://doi.org/10.1016/J.INVENT.2024.100775
• Bouabida, K., Lebouché, B., & Pomey, M.-P. (2022). Telehealth and COVID-19 pandemic: An overview of the telehealth use, advantages, challenges, and opportunities during COVID-19 pandemic. Healthcare, 10(11), 2293. https://doi.org/10.3390/healthcare10112293
• Brezing, C. A., & Brixner, D. I. (2022). The rise of prescription digital therapeutics in behavioral health. Advances in Therapy, 39(12), 5301–5306. https://doi.org/10.1007/S12325-022-02320-0
• Byambasuren, O., Beller, E., Hoffmann, T., & Glasziou, P. (2020). mHealth app prescription in Australian general practice: Pre-post study. JMIR mHealth and uHealth, 8(6), e16497. https://doi.org/10.2196/16497
• Carmina, D., Benfenati, V., Simonelli, C., Rotolo, A., Cardano, P., Grovale, N., ... & De Seta, F. (2023). Innovative solutions for disease management. Bioelectronic Medicine, 9(1), 28.
• Carolan, J. E., McGonigle, J., Dennis, A., Lorgelly, P., & Banerjee, A. (2022). Technology-enabled, evidence-driven, and patient-centered: The way forward for regulating software as a medical device. JMIR Medical Informatics, 10(1), e34038. https://doi.org/10.2196/34038
• Chen, J., Amaize, A., & Barath, D. (2021). Evaluating telehealth adoption and related barriers among hospitals located in rural and urban areas. Journal of Rural Health, 37(4), 801–811. https://doi.org/10.1111/JRH.12534
• Chung, J.-Y. (2019). Digital therapeutics and clinical pharmacology. Translational and Clinical Pharmacology, 27(1), 6. https://doi.org/10.12793/TCP.2019.27.1.6
• Colnar, S., Dimovski, V., Grah, B., Rogelj, V., & Bogataj, D. (2020). Smart home supporting integrated health and care services for older adults in the community: Literature review and research agenda. 2020 24th International Conference on System Theory, Control and Computing (ICSTCC 2020) Proceedings, 526–531. https://doi.org/10.1109/ICSTCC50638.2020.9259711
• Crisafulli, S., Santoro, E., Recchia, G., & Trifirò, G. (2022). Digital therapeutics in perspective: From regulatory challenges to post-marketing surveillance. Frontiers in Drug Safety and Regulation, 2, 900946. https://doi.org/10.3389/FDSFR.2022.900946
• Dang, A., Arora, D., & Rane, P. (2020). Role of digital therapeutics and the changing future of healthcare. Journal of Family Medicine and Primary Care, 9(5), 2207. https://doi.org/10.4103/JFMPC.JFMPC_105_20
• Deliu, N., & Chakraborty, B. (2025). Artificial intelligence-based decision support systems for precision and digital health. In Frontiers of Statistics and Data Science (pp. 1–38). Springer Nature Singapore. https://doi.org/10.1007/978-981-96-0742-6_1
• Denecke, K., May, R., Gabarron, E., & Lopez-Campos, G. H. (2023). Assessing the potential risks of digital therapeutics (DTX): The DTX risk assessment canvas. Journal of Personalized Medicine, 13(10), 1523. https://doi.org/10.3390/JPM13101523
• Duffy, L. V., Evans, R., Bennett, V., Hady, J. M., & Palaniappan, P. (2023). Therapeutic relational connection in telehealth: Concept analysis. Journal of Medical Internet Research, 25, e43303.
• Ezeamii, V. C., Okobi, O. E., Wambai-Sani, H., Perera, G. S., Zaynieva, S., Okonkwo, C. C., … Obiefuna, N. G. (2024). Revolutionizing healthcare: How telemedicine is improving patient outcomes and expanding access to care. Cureus, 16(7), e63881. https://doi.org/10.7759/CUREUS.63881
• Facchinetti, G., Petrucci, G., Albanesi, B., De Marinis, M. G., & Piredda, M. (2023). Can smart home technologies help older adults manage their chronic condition? A systematic literature review. International Journal of Environmental Research and Public Health, 20(2), 1205. https://doi.org/10.3390/IJERPH20021205
• Farzan, M., Ebrahimi, H., Pourali, M., & Sabeti, F. (2025). Artificial intelligence-powered cognitive behavioral therapy chatbots, a systematic review. Iranian Journal of Psychiatry, 20(1), 100–108. https://doi.org/10.18502/IJPS.V20I1.17395
• Fassbender, A., Donde, S., Silva, M., Friganovic, A., Stievano, A., Costa, E., … van Vugt, J. (2024). Adoption of digital therapeutics in Europe. Therapeutics and Clinical Risk Management, 20, 939–954. https://doi.org/10.2147/TCRM.S489873
• Folkmann, E. J., Hughes, M. C., Khan, U. A., & Vaezi, M. (2024). Examining noncommunicable diseases using satellite imagery: A systematic literature review. BMC Public Health, 24(1), 2774. https://doi.org/10.1186/S12889-024-20316-Z
• Forman-Hoffman, V. L., Nelson, B. W., Ranta, K., Nazander, A., Hilgert, O., & de Quevedo, J. (2021a). Significant reduction in depressive symptoms among patients with moderately-severe to severe depressive symptoms after participation in a therapist-supported, evidence-based mobile health program delivered via a smartphone app. Internet Interventions, 25, 100408. https://doi.org/10.1016/J.INVENT.2021.100408
• Fürstenau, D., Gersch, M., & Schreiter, S. (2023). Digital therapeutics (DTx). Business and Information Systems Engineering, 65(3), 349–360.
• Gazit, T., Gutman, M., & Beatty, A. L. (2021). Assessment of hypertension control among adults participating in a mobile technology blood pressure self-management program. JAMA Network Open, 4(10), e2127008. https://doi.org/10.1001/JAMANETWORKOPEN.2021.27008
• Gelner, H., Karska, J., Gawęda, Ł., Samochowiec, J., & Misiak, B. (2023). Effects of the interaction between PTSD and ADHD symptoms on the level of reporting psychotic-like experiences: Findings from a non-clinical population. Frontiers in Psychiatry, 14, 1232606. https://doi.org/10.3389/FPSYT.2023.1232606
• Gensorowsky, D., Witte, J., Batram, M., & Greiner, W. (2022). Market access and value-based pricing of digital health applications in Germany. Cost Effectiveness and Resource Allocation, 20(1), 1–14.
• Getov, I., Panayotova, D., Dobrev, S., Dimitrova, M., & Petkova, V. (2025). Opportunities for implementing digital applications to monitor the impact of risk-minimization measures within the pharmacovigilance process: Scoping review of published literature. PHARMACIA, 72, 1–6. https://doi.org/10.3897/PHARMACIA.72.E143323
• Ghose, A., Guo, X., Li, B., & Dang, Y. (2022). Empowering patients using smart mobile health platforms: Evidence from a randomized field experiment. MIS Quarterly, 46(1), 151–192. https://doi.org/10.25300/MISQ/2022/16201
• Goeldner, M., & Gehder, S. (2024). Digital health applications (DiGAs) on a fast track: Insights from a data-driven analysis of prescribable digital therapeutics in Germany from 2020 to mid-2024. Journal of Medical Internet Research, 26, e59013. https://doi.org/10.2196/59013
• Goh, Y. S., Yong, J. Q. Y. O., Chee, B. Q. H., Kuek, J. H. L., & Ho, C. S. H. (2022). Machine learning in health promotion and behavioral change: Scoping review. Journal of Medical Internet Research, 24(6), e35831. https://doi.org/10.2196/35831
• Gorrepati, L. P. (2024). Integrating AI with electronic health records (EHRs) to enhance patient care. International Journal of Health Sciences, 7(8), 38–50. https://doi.org/10.47941/IJHS.2368
• Gupte, T., Nitave, T., & Gobburu, J. (2025). Regulatory landscape of accelerated approval pathways for medical devices in the United States and the European Union. Frontiers in Medical Technology, 7, 1586070.
• Hacker, K. (2024). The burden of chronic disease. Mayo Clinic Proceedings: Innovations, Quality and Outcomes, 8(1), 112–119. https://doi.org/10.1016/j.mayocpiqo.2023.08.005
• Hareem, A., Stupans, I., Park, J. S., Stevens, J. E., & Wang, K. (2024). Electronic health records and e-prescribing in Australia: An exploration of technological utilisation in Australian community pharmacies. International Journal of Medical Informatics, 187, 105472. https://doi.org/10.1016/J.IJMEDINF.2024.105472
• He, F., Qi, Y., Zhou, Y., Cao, A., Yue, X., Fang, S., & Zheng, Y. (2023). Meta-analysis of the efficacy of digital therapies in children with attention-deficit hyperactivity disorder. Frontiers in Psychiatry, 14, 1054831. https://doi.org/10.3389/FPSYT.2023.1054831
• Heinz, M. V., Mackin, D. M., Trudeau, B. M., Bhattacharya, S., Wang, Y., Banta, H. A., … Jacobson, N. C. (2025). Randomized trial of a generative AI chatbot for mental health treatment. NEJM AI, 2(4), AIoa2400802. https://doi.org/10.1056/AIOA2400802
• Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., … Zarrinpar, A. (2020). Enabling technologies for personalized and precision medicine. Trends in Biotechnology, 38(5), 497–518. https://doi.org/10.1016/j.tibtech.2019.12.021
• Holfelder, M., Mulansky, L., Schlee, W., Baumeister, H., Schobel, J., Greger, H., ... & Pryss, R. (2021). Medical device regulation efforts for mHealth apps during the COVID-19 pandemic—An experience report of corona check and corona health. J, 4(2), 206–222. https://doi.org/10.3390/j4020017
• Hu, P., Hu, L., Wang, F., & Mei, J. (2023). Editorial: Computing and artificial intelligence in digital therapeutics. Frontiers in Medicine, 10, 1330686.
• Huang, G., Chen, X., & Liao, C. (2025). AI-driven wearable bioelectronics in digital healthcare. Biosensors, 15(7), 410. https://doi.org/10.3390/BIOS15070410
• Huh, K. Y., Oh, J., Lee, S., & Yu, K. S. (2022). Clinical evaluation of digital therapeutics: Present and future. Healthcare Informatics Research, 28(3), 188–197. https://doi.org/10.4258/HIR.2022.28.3.188
• Hurvitz, N., Azmanov, H., Kesler, A., & Ilan, Y. (2021). Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases. European Journal of Human Genetics, 29(10), 1485. https://doi.org/10.1038/S41431-021-00928-4
• Jain, D. (2023, March). Regulation of digital healthcare in India: Ethical and legal challenges. In Healthcare, 11(6), 911. MDPI. https://doi.org/10.3390/HEALTHCARE11060911
• Jharbade, R. (2025). Digital therapeutics: Transforming healthcare through AI & emerging technology. IOSR Journal of Dental and Medical Sciences, 24(1), 40–49. https://doi.org/10.9790/0853-2401014049
• Jiang, N., Yu, X., Yang, Y., Li, G., He, C., Wang, M. P., & Rao, K. (2025). Digital therapeutics in China: Comprehensive review. Journal of Medical Internet Research, 27(1), e70955. https://doi.org/10.2196/70955
• Jürgens, K., Raddatz, A., Tausendfreund, F., & Clemens, T. (2024). Market access regulations for mHealth applications in Germany, Austria and Switzerland: A review. Health Policy and Technology, 13(5), 100934. https://doi.org/10.1016/J.HLPT.2024.100934
• Kadakia, K. T., Dhruva, S. S., Ross, J. S., Burke, J. F., Johnston, J. L., Ramachandran, R., ... & Rathi, V. K. (2025). FDA authorization of therapeutic devices under the breakthrough devices program. JAMA Internal Medicine, 185(8), 996–1004.
• Kalagara, R., Chennareddy, S., Scaggiante, J., Matsoukas, S., Bhimani, A., Smith, C., … Kellner, C. P. (2022). Blood pressure management through application-based telehealth platforms: A systematic review and meta-analysis. Journal of Hypertension, 40(7), 1249–1256. https://doi.org/10.1097/HJH.0000000000003164
• Kaldy, J. (2020). Digital therapeutics: Health care wired for the future. The Senior Care Pharmacist, 35(8), 338–344. https://doi.org/10.4140/TCP.N.2020.338
• Kamal, S., Khan, Z., & Karim, N. (2021). Predictive analytics in personalized medicine: Early detection of chronic diseases through artificial intelligence. International Journal of Multidisciplinary Research and Growth Evaluation, 2(6), 462–468.
• Kannenberg, S., Voggel, J., Thieme, N., Witt, O., Pethahn, K. L., Schütt, M., ... Schröder, T. (2026). Unlocking potential: Personalized lifestyle therapy for type 2 diabetes through a predictive algorithm-driven digital therapeutic. Journal of Diabetes Science and Technology, 20(1), 113–123. https://doi.org/10.1177/19322968241266821
• Kario, K., Nomura, A., Harada, N., Tanigawa, T., So, R., Nakagawa, K., ... Satake, K. (2020). A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB-DH1 trial. The Journal of Clinical Hypertension, 22(9), 1713–1722. https://doi.org/10.1111/jch.13993
• Kaushik, V., & Gupta, P. (2025). The future of personalized medicine in India. IJFMR–International Journal for Multidisciplinary Research, 7(3). https://doi.org/10.36948/ijfmr.2025.v07i03.47618
• Kim, C., Choi, H. E., Rhee, C. K., Song, J. H., & Lee, J. H. (2024). Efficacy of digital therapeutics for pulmonary rehabilitation: A multi-center, randomized controlled trial. Life, 14(4). [Add DOI if available]
• Kim, J. E., Park, T. S., & Kim, K. J. (2022). The clinical effects of type 2 diabetes patient management using digital healthcare technology: A systematic review and meta-analysis. Healthcare, 10(3), 522. https://doi.org/10.3390/healthcare10030522
• Kukreja, P., Saxena, K., & Santra, S. (2023). Digital therapeutics and their integration into healthcare systems: A public health perspective. HPHR Journal, 75(75). https://doi.org/10.54111/0001/WWW1
• Lahariya, C. (2020). Health and wellness centers to strengthen primary health care in India: Concept, progress and ways forward. Indian Journal of Pediatrics, 87(11), 916–929. https://doi.org/10.1007/S12098-020-03359-Z
• Lakhan, S. E. (2025). Decoding FDA labeling of prescription digital therapeutics: A cross-sectional regulatory study. Cureus, 17(5), e84468. https://doi.org/10.7759/CUREUS.84468
• Lee, E. W. J., Bao, H., Wu, Y. S., Wang, M. P., Wong, Y. J., & Viswanath, K. (2024). Examining health apps and wearable use in improving physical and mental well-being across U.S., China, and Singapore. Scientific Reports, 14(1), 10779. https://doi.org/10.1038/S41598-024-61268-Z
• Lee, Y. B., Kim, G., Jun, J. E., Park, H., Lee, W. J., Hwang, Y. C., & Kim, J. H. (2023). An integrated digital health care platform for diabetes management with AI-based dietary management: 48-week results from a randomized controlled trial. Diabetes Care, 46(5), 959–966. https://doi.org/10.2337/DC22-1929
• Liang, J., Fang, Q., Jiao, X., Xiang, P., Ma, J., Zhang, Z., ... Lei, J. (2025). Approved trends and product characteristics of digital therapeutics in four countries. NPJ Digital Medicine, 8(1), 308. https://doi.org/10.1038/S41746-025-01660-9
• Lievevrouw, E., Marelli, L., & Van Hoyweghen, I. (2024). Weaving EU digital health policy into national healthcare practices: The making of a reimbursement standard for digital health technologies in Belgium. Social Science & Medicine, 346, 116620. https://doi.org/10.1016/j.socscimed.2024.116620
• Lin, B., & Wu, S. (2022). Digital transformation in personalized medicine with artificial intelligence and the Internet of Medical Things. OMICS: A Journal of Integrative Biology, 26(2), 77–81. https://doi.org/10.1089/omi.2021.0037
• Liquori, G., Pio Posa, V., De Leo, A., Giannetta, N., Di Simone, E., Di Muzio, M., & Dionisi, S. (2024). The use of mHealth in promoting therapeutic adherence: A scoping review. CIN: Computers, Informatics, Nursing, 42(1), 71–79. https://doi.org/10.1097/CIN.0000000000001062
• Liu, L., Guo, J., Jiao, X., & You, L. (2025). The effect of digital therapeutics intervention on improving hypertension management in adults: A meta-analysis of randomized controlled trials. Hypertension Research, 48(2), 456–469. https://doi.org/10.1038/S41440-024-01892-4
• Mäder, M., Timpel, P., Schönfelder, T., Militzer-Horstmann, C., Scheibe, S., Heinrich, R., & Häckl, D. (2023). Evidence requirements of permanently listed digital health applications (DiGA) and their implementation in the German DiGA directory: An analysis. BMC Health Services Research, 23(1), 1–25.
• Mann, D. M., & Lawrence, K. (2022). Reimagining connected care in the era of digital medicine. JMIR mHealth and uHealth, 10(4), e34483. https://doi.org/10.2196/34483
• Mantovani, A., Leopaldi, C., Nighswander, C. M., & Di Bidino, R. (2023). Access and reimbursement pathways for digital health solutions and in vitro diagnostic devices: Current scenario and challenges. Frontiers in Medical Technology, 5, 1101476. https://doi.org/10.3389/fmedt.2023.1101476
• Martínez-García, M., & Hernández-Lemus, E. (2022). Data integration challenges for machine learning in precision medicine. Frontiers in Medicine, 8, 784455. https://doi.org/10.3389/fmed.2021.784455
• Meheli, S., Sinha, C., & Kadaba, M. (2022). Understanding people with chronic pain who use a cognitive behavioral therapy-based artificial intelligence mental health app (Wysa): Mixed methods retrospective observational study. JMIR Human Factors, 9(2), e35671. https://doi.org/10.2196/35671
• Mennella, C., Maniscalco, U., De Pietro, G., & Esposito, M. (2024). Ethical and regulatory challenges of AI technologies in healthcare: A narrative review. Heliyon, 10(4), e26297. https://doi.org/10.1016/j.heliyon.2024.e26297
• Mia Md Tofayel Gonee Manik. (2021). Leveraging AI-powered predictive analytics for early detection of chronic diseases: A data-driven approach to personalized medicine. Nanotechnology Perceptions, 17(3), 269–288. https://doi.org/10.62441/NANO-NTP.V17I3.5444
• Miao, B. Y., Arneson, D., Wang, M., & Butte, A. J. (2022). Open challenges in developing digital therapeutics in the United States. PLOS Digital Health, 1(1), e0000008.
• Michaud, T. L., Ern, J., Scoggins, D., & Su, D. (2021). Assessing the impact of telemonitoring-facilitated lifestyle modifications on diabetes outcomes: A systematic review and meta-analysis. Telemedicine and e-Health, 27(2), 124–136. https://doi.org/10.1089/TMJ.2019.0319
• Mirza, M., Jabeen, H., & Fatima, A. (2025). Artificial intelligence in digital therapeutics for optimized healthcare: Review article. Journal of Pharma Insights and Research, 3(2), 346–357. https://doi.org/10.69613/G5MBDA64
• Mohsen, F., Al-Absi, H. R. H., Yousri, N. A., El Hajj, N., & Shah, Z. (2023). A scoping review of artificial intelligence-based methods for diabetes risk prediction. NPJ Digital Medicine, 6(1), 1–15. https://doi.org/10.1038/s41746-023-00933-5
• Molla, G., & Bitew, M. (2024). Revolutionizing personalized medicine: Synergy with multi-omics data generation, main hurdles, and future perspectives. Biomedicines, 12(12), 2750.
• Morita, P. P. (2020). Design of mobile health technology. In Design for health (pp. 87–102). Academic Press.
• Morita, P. P. (2020). Design of mobile health technology. In Design for health: Applications of human factors (pp. 87–102).
• Murthi, S., Martini, N., Falconer, N., & Scahill, S. (2024). Evaluating EHR-integrated digital technologies for medication-related outcomes and health equity in hospitalised adults: A scoping review. Journal of Medical Systems, 48(1), 79. https://doi.org/10.1007/S10916-024-02097-5
• Mwogosi, A., & Mambile, C. (2025). AI integration in EHR systems in developing countries: A systematic literature review using the TCCM framework. Information Discovery and Delivery. https://doi.org/10.1108/IDD-07-2024-0097
• Naik, A., Nalepa, J., Wijata, A. M., Mahon, J., Mistry, D., Knowles, A. T., … Ortega-Martorell, S. (2025). Artificial intelligence and digital twins for the personalised prediction of hypertension risk. Computers in Biology and Medicine, 196, 110718.
• Naithani, N., Atal, A. T., Tilak, T. V. S. V. G. K., Vasudevan, B., Misra, P., & Sinha, S. (2021). Precision medicine: Uses and challenges. Medical Journal Armed Forces India, 77(3), 258–265. https://doi.org/10.1016/J.MJAFI.2021.06.020
• Nedungadi, P. P., Menon, R., Gutjahr, G., Erickson, L., & Raman, R. (2018). Towards an inclusive digital literacy framework for digital India. Education and Training, 60(6), 516–528. https://doi.org/10.1108/ET-03-2018-0061
• Nomura, A. (2023). Digital health, digital medicine, and digital therapeutics in cardiology: Current evidence and future perspective in Japan. Hypertension Research, 46(9), 2126–2134.
• Ora, J., Prendi, E., Attinà, M. L., Cazzola, M., Calzetta, L., & Rogliani, P. (2022). Efficacy of respiratory tele-rehabilitation in COPD patients: Systematic review and meta-analysis. Monaldi Archives for Chest Disease = Archivio Monaldi per Le Malattie Del Torace, 92(4). https://doi.org/10.4081/MONALDI.2022.2105
• Palanica, A., Docktor, M. J., Lieberman, M., & Fossat, Y. (2020). The need for artificial intelligence in digital therapeutics. Digital Biomarkers, 4(1), 21. https://doi.org/10.1159/000506861
• Palmer, C. E., Marshall, E., Millgate, E., Warren, G., Ewbank, M., Cooper, E., … Blackwell, A. D. (2025). Combining artificial intelligence and human support in mental health: Digital intervention with comparable effectiveness to human-delivered care. Journal of Medical Internet Research, 27, e69351. https://doi.org/10.2196/69351
• Patel, K., Patel, H., Shah, D., Patel, D., Savaliya, N., Bambharoliya, T., … Patel, A. (2024). Unlocking the potential: A comprehensive review for the synthesis of benzofuran derivatives. Current Green Chemistry, 11(1), 12–36.
• Perakslis, E., & Ginsburg, G. S. (2021). Digital health—The need to assess benefits, risks, and value. JAMA, 325(2), 127–128. https://doi.org/10.1001/JAMA.2020.22919
• Phan, P., Mitragotri, S., & Zhao, Z. (2023). Digital therapeutics in the clinic. Bioengineering & Translational Medicine, 8(4), e10536. https://doi.org/10.1002/BTM2.10536
• Prabhughate, A., & Gharat, C. (2024). Digital therapeutics for cardiovascular diseases in India—A low-middle-income country’s perspective: A systematic review. International Journal of Research in Medical Sciences, 12(6), 2071–2078. https://doi.org/10.18203/2320-6012.ijrms20241561
• Rasekaba, T. M., Pereira, P., Vinaya Rani, G., Johnson, R., McKechnie, R., & Blackberry, I. (2022). Exploring telehealth readiness in a resource limited setting: Digital and health literacy among older people in rural India (DAHLIA). Geriatrics, 7(2). https://doi.org/10.3390/geriatrics7020028
• Recchia, G., & Gussoni, G. (2023). Digital therapeutics: Scientific, technological, and regulatory challenges. In Personalized medicine meets artificial intelligence: Beyond “hype”, towards the metaverse (pp. 37–50). Springer International Publishing. https://doi.org/10.1007/978-3-031-32614-1_4
• Refolo, P., Sacchini, D., Raimondi, C., & Spagnolo, A. G. (2022). Ethics of digital therapeutics (DTx). European Review for Medical and Pharmacological Sciences, 26(18), 6418–6423. https://doi.org/10.26355/EURREV_202209_29741
• Rinn, R., Gao, L., Schoeneich, S., Dahmen, A., Anand Kumar, V., Becker, P., & Lippke, S. (2023). Digital interventions for treating post-COVID or long-COVID symptoms: Scoping review. Journal of Medical Internet Research, 25, e45711. https://doi.org/10.2196/45711
• Rubinsztain, J. (2022). Development and application of digital therapeutics to improve outcomes in managing chronic conditions. Journal of Clinical Engineering, 47(1), 17–19. https://doi.org/10.1097/JCE.0000000000000494
• S, D., & R, K. (2024). A review of the regulatory challenges of personalized medicine. Cureus, 16(8). https://doi.org/10.7759/CUREUS.67891
• Salsabili, M., Tesell, M., Alcusky, M., Greenwood, B. C., Huang, D., Lenz, K., & Dave, J. (2023). Prescription digital therapeutics: Applying Medicaid experience to value assessment and formulary management. 29(6), 685–691. https://doi.org/10.18553/JMCP.2023.29.6.685
• Schliess, F., Affini Dicenzo, T., Gaus, N., Bourez, J. M., Stegbauer, C., Szecsenyi, J., … Heinemann, L. (2024). The German fast track toward reimbursement of digital health applications: Opportunities and challenges for manufacturers, healthcare providers, and people with diabetes. Journal of Diabetes Science and Technology, 18(2), 470–476. https://doi.org/10.1177/19322968221121660
• Schmidt, L., Pawlitzki, M., Renard, B. Y., Meuth, S. G., & Masanneck, L. (2024). The three-year evolution of Germany’s digital therapeutics reimbursement program and its path forward. NPJ Digital Medicine, 7(1), 139. https://doi.org/10.1038/S41746-024-01137-1
• Schudt, F., Rohloff-Meinke, C., Koehler, N., Sohrabi, K., Gross, V., & Scholtes, M. (2022). A comparative overview of digital health applications between Belgium and Germany. Current Directions in Biomedical Engineering, 8(2), 509–511. https://doi.org/10.1515/CDBME-2022-1130
• Seo, Y. C., Yong, S. Y., Choi, W. W., & Kim, S. H. (2024). Meta-analysis of studies on the effects of digital therapeutics. Journal of Personalized Medicine, 14(2), 157. https://doi.org/10.3390/JPM14020157
• Shafai, G., & Aungst, T. D. (2023). Prescription digital therapeutics: A new frontier for pharmacists and the future of treatment. Journal of the American Pharmacists Association, 63(4), 1030–1034. https://doi.org/10.1016/J.JAPH.2023.03.012
• Shah, A., & Shah, S. (2023). Digital therapeutics-a new era in health care. National Journal of Physiology Pharmacy and Pharmacology, 13(11), 2190–2196.
• Shantz, E., & Elliott, S. J. (2020). Chronic disease. In International Encyclopedia of Human Geography (2nd ed., pp. 187–191).
• Sharma, A., & Luthra, G. (2023). Implementing a risk-based approach to quality management system ISO-13485 processes in compliance with EUMDR 2017/745 for medical device industry. Journal of Pharmaceutical Research International, 35(13), 8–19. https://doi.org/10.9734/JPRI/2023/V35I137365
• Sharma, R. S., Rohatgi, A., Jain, S., & Singh, D. (2023). The Ayushman Bharat Digital Mission (ABDM): Making of India’s digital health story. CSI Transactions on ICT, 11(1), 3–9. https://doi.org/10.1007/S40012-023-00375-0
• Sharma, V., Ali, I., Van Der Veer, S., Martin, G., Ainsworth, J., & Augustine, T. (2021). Adoption of clinical risk prediction tools is limited by a lack of integration with electronic health records. BMJ Health & Care Informatics, 28(1), e100253. https://doi.org/10.1136/BMJHCI-2020-100253
• Shin, H. J., Cho, I. T., Choi, W. S., Kim, H. R., Kang, M. B., & Yang, W. J. (2024). Digital therapeutics in Korea: Current status, challenges, and future directions—A narrative review. Journal of Yeungnam Medical Science, 42, 8. https://doi.org/10.12701/JYMS.2024.01004
• Sindakis, S., & Showkat, G. (2024). The digital revolution in India: Bridging the gap in rural technology adoption. Journal of Innovation and Entrepreneurship, 13(1), 29. https://doi.org/10.1186/s13731-024-00380-w
• Singh, K., & Landman, A. B. (2017). Mobile health. In Key advances in clinical informatics: Transforming health care through health information technology (pp. 183–196).
• Stamatis, C. A., Farlow, D. N., Mercaldi, C., Suh, M., Maple, A., Savarese, A., … Kollins, S. H. (2024). Two single arm trials of AKL-T01, a digital therapeutic for adolescents and adults with ADHD. NPJ Mental Health Research, 3(1), 30. https://doi.org/10.1038/S44184-024-00075-W
• Subramanian, A., Huang, Y., Nagesh, N., Wang, L., Liu, Z., Hou, W., ... & Rahmani, A. (2024). Long term remote patient monitoring reduces blood pressure in patients with stage II hypertension. Circulation, 150(Suppl. 1), A4140290–A4140290. https://doi.org/10.1161/circ.150.suppl_1.4140290
• Sugandh, F., Chandio, M., Raveena, F., Kumar, L., Karishma, F., Khuwaja, S., … Kumar, S. (2023). Advances in the management of diabetes mellitus: A focus on personalized medicine. Cureus, 15(8). https://doi.org/10.7759/CUREUS.43697
• Sui, W., & Facca, D. (2020). Digital health in a broadband land: The role of digital health literacy within rural environments. Health Science Inquiry, 11(1), 140–143. https://doi.org/10.29173/HSI294
• Vasdev, N., Gupta, T., Pawar, B., Bain, A., & Tekade, R. K. (2024). Navigating the future of health care with AI-driven digital therapeutics. Drug Discovery Today, 29(9), 104110. https://doi.org/10.1016/J.DRUDIS.2024.104110
• Wang, C., Lee, C., & Shin, H. (2023). Digital therapeutics from bench to bedside. NPJ Digital Medicine, 6(1), 38. https://doi.org/10.1038/S41746-023-00777-Z
• Watson, A., Chapman, R., Shafai, G., & Maricich, Y. A. (2023). FDA regulations and prescription digital therapeutics: Evolving with the technologies they regulate. Frontiers in Digital Health, 5, 1086219.
• Watson, Alastair, & Wilkinson, T. M. A. (2022). Digital healthcare in COPD management: A narrative review on the advantages, pitfalls, and need for further research. Therapeutic Advances in Respiratory Disease, 16, 17534666221075492. https://doi.org/10.1177/17534666221075493
• Wojtara, M., Rana, E., Rahman, T., Khanna, P., & Singh, H. (2023). Artificial intelligence in rare disease diagnosis and treatment. Clinical and Translational Science, 16(11), 2106–2111. https://doi.org/10.1111/CTS.13619
• Xia, S. H., Narayanan, M. M., Swamy, V., & Franson, K. (2025). Therapeutic evaluation and utilization analysis of mental health prescription digital therapeutics within the current regulatory landscape. Pharmacy, 13(1), 19. https://doi.org/10.3390/PHARMACY13010019
• Yang, L., Zhang, M., Jia, L., Yan, Z., & Yin, Q. (2025). Understanding digital therapeutics in disease self-management: A systematic literature review. Technology in Society, 81, 102831. https://doi.org/10.1016/J.TECHSOC.2025.102831
• Yoo, J. H., Jeong, H., & Chung, T. M. (2023). Cutting-edge technologies for digital therapeutics: A review and architecture proposals for future directions. Applied Sciences, 13(12), 6929. https://doi.org/10.3390/APP13126929
• Zahedani, A. D., Veluvali, A., McLaughlin, T., Aghaeepour, N., Hosseinian, A., Agarwal, S., … Snyder, M. (2023). Digital health application integrating wearable data and behavioral patterns improves metabolic health. NPJ Digital Medicine, 6(1), 216. https://doi.org/10.1038/S41746-023-00956-Y
• Zhao, L., Agazzi, H., Du, Y., Meng, H., Maku, R., Li, K., … Fang, S. (2024). A digital cognitive-physical intervention for attention-deficit/hyperactivity disorder: Randomized controlled trial. Journal of Medical Internet Research, 26, e55569. https://doi.org/10.2196/55569
• Zheng, Z., Zhu, R., Peng, I., Xu, Z., & Jiang, Y. (2024). Wearable and implantable biosensors: Mechanisms and applications in closed-loop therapeutic systems. Journal of Materials Chemistry B, 12(35), 8577–8604. https://doi.org/10.1039/D4TB00782D
• Zhu, S., Gilbert, M., Chetty, I., & Siddiqui, F. (2022). The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use. International Journal of Medical Informatics, 165, 104828. https://doi.org/10.1016/J.IJMEDINF.2022.104828
• Zhuang, M., Hassan, I. I., W Ahmad, W. M. A., Abdul Kadir, A., Liu, X., Li, F., … Song, S. (2025). Effectiveness of digital health interventions for chronic obstructive pulmonary disease: Systematic review and meta-analysis. Journal of Medical Internet Research, 27(1), e76323. https://doi.org/10.2196/76323
• Zoder-Martell, K. A., Markelz, A. M., Floress, M. T., Skriba, H. A., & Sayyah, L. E. N. (2020). Technology to facilitate telehealth in applied behavior analysis. Behavior Analysis in Practice, 13(3), 596. https://doi.org/10.1007/S40617-020-00449-4
• Zovi, A., Ferrara, F., Gelmi, M., Messina, N., Pagani, A. A. M., Patti, T., … Langella, R. (2025). Digital therapeutics as a new weapon against diseases: Focus on the current European legislation and possible therapeutic strategies. Expert Review of Medical Devices, 22(2), 141–147. https://doi.org/10.1080/17434440.2025.2457468